IVF used by some to avoid passing on genetic diseases to offspring
By Jamie Talan,
The Washington Post
| 12. 04. 2021
By Fotograf Kallestad, Gorm / NTB Scanpix. CC BY NC 4.0
In vitro fertilization (IVF), widely known as a way to help infertile couples have babies, has taken on another remarkable use: It has become part of a procedure to help families keep from passing on serious genetic diseases to their children.
Parents who know they carry genetic mutations for muscular dystrophy, cystic fibrosis, sickle cell anemia, breast cancer, Huntington’s disease, Alzheimer’s and other inherited diseases can undergo IVF, where the mother’s eggs are collected and combined with sperm in a dish, and another procedure called preimplantation genetic testing (PGT), in which embryos are screened for the particular mutation and only disease-free embryos can be implanted in the mother.
“I don’t know why more people don’t embrace these technologies,” said Greg McGuire, 38, of Fishers, Ind., who was diagnosed with Becker muscular dystrophywhen he was 8 years old, one of several family members with the inherited genetic mutation. Because it is passed down from mother to son — and his mother only had sisters — no one in the...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...